Alrawi S, Winston J, Tan D, Gibbs JF, Loree TR, Hicks WL, Regual N, Lor'e J Jr. (2005) Primary Adenocarcinoma of Cervical Esophagus. Case Report and Review of the Literature. Journal of Experimental and Clinical Cancer Research (Jan), 24(2): 207-212.
Chu QD, Hurd TC, Harvey S, Martinick M, Markus G, Tan D, Gibbs JF, Loree TR. (2004) Overexpression of Urinary Plasminogen Activator (uPA) Protein and mRNA in Thyroid Carcinogenesis. Diagnostic Molecular Pathology (Jan), 13(4): 241-246.
Evans SS, Ostberg JR, O‘Leary K, Gibbs J, Repasky EA, Kraybill W. (2002) A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models. International Joournal of Hyperthermia (Jan), 18(3): 253-266.
Chu QD, Al-kasspooles MF, Smith JL, Nava HR, Douglass HO, Driscoll D, Gibbs JF. (2002) Is glucagonoma of the pancreas a curable disease?. Int J Pancreatol (Jan), 29(3): 155-162.
Gergel TJ, Proulx G, Leichman L, Nava H, Blumenson L, Khusalani N, Leichman C, Bodnar L, Gibbs J, Douglass H, Smith JL, Kuettel M. (2002) Effect of Concurrent Radiation Therapy and Chemotherapy on Pulmonary Function in Patients with Esophageal Cancer: Dose-Volume Histogram Analysis. Journal of Radiation Oncology Biology and Physics. (Jan), 8(6): 451-460.
Gergel TJ, Leichman L, Nava HR, Blumenson LE, Loewen GM, Gibbs JE, Khushalani NI, Leichman CG, Bodnar LM, Douglass HO, Smith JL, Kuettel MR, Proulx GM. (2002) Effect of concurrent radiation therapy and chemotherapy on pulmonary function in patients with esophageal cancer: dose-volume histogram analysis. Cancer J (Jan), 8(6): 451-460.
Kahlenberg MS, Kane JM, Kanter PM, Weber TK, Gibbs JF, Rodriguez-Bigas MA, Petrelli NJ. (2001) Hepatic lymphatic mapping: a pilot study for porta hepatis lymph node identification. Cancer Invest (Jan), 19(3): 256-260.
Gibbs JF, Huang, P., Lee R, McGrath BE, Sundquist J, McKinley, B., Driscoll, D., Kraybill WG. (2001) Malignant Fibrous Histiocytoma: An Institutional Review. Cancer Investigation (Jan), 19(1): 20-27.
Gibbs JF, Lee R, Driscoll, D., McGrath BE, Mindell, E., Kraybill WG. (2000) Clinical Importance of Late Reoccurence in Soft-Tissue Sarcomas. Journal of Surgical Oncology (Jan), 73: 81-86.
Beitler AL, Virgo KS, Johnson FE, Gibbs JF, Kraybill WG. (2000) Current follow-up strategies after potentially curative resection of extremity sarcomas: results of a survey of the members of the society of surgical oncology. Cancer (Jan), 88(4): 777-785.
Kane JM, Gibbs JF, McGrath BE, Loree TR, Kraybill WG. (2000) Large, deep high-grade extremity sarcomas: when is a myocutaneous flap reconstruction necessary?. Surgical Oncology (Jan), 8(4): 205-210.
Sabel MS, Gibbs JF, Cheney R, McKinley BP, Lee JS, Kraybill WG. (2000) Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute-designated cancer center. Surgery (Jan), 128(4): 556-563.
Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. (2000) Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol (Jan), 7(9): 705-712.
Finley JW, Gibbs JF, Rodriguez LM, Letourneau R, Driscoll D, Kraybill W. (2000) Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system. Am Surg (Jan), 66(6): 527-531.
Whooley BP*, Gibbs JF, Mooney BE*, McGrath BE, Kraybill WG. (2000) Primary extremity sarcoma: what is the appropriate follow-up?. Ann Surg Oncol (Jan), 7(1): 9-14.
Gibbs JF, Huang PP, Zhang PJ, Kraybill WG, Cheney R. (1999) Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol (Jan), 6(7): 699-704.
Barnwell JM, Arredondo MA, Kollmorgen D, Gibbs JF, Lamonica D, Carson W, Zhang P, Winston J, Edge SB. (1998) Sentinel node biopsy in breast cancer. Ann Surg Oncol (Mar), 5(2): 126-130.
Yin MB, Guo B, Voigt W, Vanhoefer U, Gibbs JF, Skenderis BS, Frank C, Wrzosek C, Rustum YM. (1998) Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein. Biochim Biophys Acta (Jan), 1401(3): 265-276.
Gibbs JF, Weber TK, Rodriguez-Bigas MA, Driscoll DL, Petrelli NJ. (1998) Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer (Jan), 82(7): 1244-1249.
Apffelstaedt JP, Driscoll DL, Spellman JE, Velez AF, Gibbs JF, Karakousis CP. (1996) Complications and outcome of external hemipelvectomy in the management of pelvic tumors. Ann Surg Oncol (Jan), 3(3): 304-309.
Schöber C, Gibbs JF, Yin MB, Slocum HK, Rustum YM. (1994) Cellular heterogeneity in DNA damage and growth inhibition induced by ICI D1694, thymidylate synthase inhibitor, using single cell assays. Biochem Pharmacol (Jan), 48(5): 997-1002.
Gibbs J, Smith JL, Douglass H. (2003) In: Surgery of Pancreatic Cancer. IN: Gastrointestinal Cancers: A companion to Sleisenger and Fordtran's Gastrointestinal and Liver Disease (eds. A.K. Rustgi, J. Crawford). , 541-547.
Gibbs J, Smith JL, Douglass H. (2001) In: Surgical Treatment of Pancreatic Carcinoma. IN: Gastrointestinal Cancers, (eds. A.K. Rustgi, J. Crawford).
Frys S, Barth MJ, Gu J, Mavis C, Gibbs JF, Czuczman MS, Hernandez-Ilizaliturri FJ. (2012) Etinostat, a Novel Histone Deacetylase (HiDAC) Inhibitor is Active in B-Cell Lymphoma Pre-Clinical Models and Enhances the Anti-Tumor Activity of Rituximab, Chemotherapy Agents and Proteasome Inhibitors. Blood, (Nov) 1649-1649
Barth MJ, Pendurti G, Mavis C, Czuczman NM, Gibbs JF, Deeb G, Czuczman MS, Hernandez-Ilizaliturri FJ. (2011) Activity of Rituximab and Ofatumumab Against Mantle Cell Lymphoma (MCL) in Vitro in MCL Cell Lines and Ex Vivo in Tumor Cells Derived From Patient Tumor Samples. Blood, (Nov) 4972-4972
Barth MJ, Hernandez-Ilizaliturri FJ, Mavis C, Tsai P, Gibbs JF, Czuczman MS. (2010) Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents in Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenograft. Blood, (Nov)
Barth MJ, Hernandez-Ilizaliturri FJ, Mavis C, Tsai P, Gibbs JF, Czuczman MS. (2010) Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenograft. Blood, (Nov) 3917-3917
Barth MJ, Hernandez-Ilizaliturri FJ, Mavis C, Tsai P, Gibbs JF, Czuczman MS. (2010) Activity of Ofatumumab (OFA), a Fully Human Monoclonal Antibody Targeting CD20, Against Rituximab (RTX)-Sensitive (RSCL) and Rituximab-Resistant Cell Lines (RRCL), In Vivo, and Primary Tumor Cells Derived from Patients with B-Cell Lymphoma. J Clin Oncol, (May) 8095-8095
Chu QD*, Khushalani N*, Javle MM, Douglass HO, Gibbs JF. (2003) Should adjuvant therapy be “standard of care” for patients with resected adenocarcinoma of the pancreas?. Annals of Surgical Oncology, (Jan) 539-545
Sarr MG, Traverso WL, Fernandez-del Castillo C, Ahrendt SA, Wilson S, Aranha GV, Evans D, Conlon K, Gillanders W, Gibbs JF, Michelassi F, Mulholland MW, Murr MM, Nealon WH, Pappas TN, Prinz RA, Shamamian P, Vickers SM, Weaver DW, Zinner MJ. (2003) The potent somatostatin analogue Vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: A prospective multicenter, double-blinded, randomized, placebo-controlled trial. Journal of the American College of Surgeons, (Jan) 556-565
Hoshi H, Wilkinson NW, Smith JL, Douglass H, Nava H, Gibbs J. (2003) Preoperative Endoscopic Ultrasound Staging Inaccurately Predicts Postoperative Tumor Depth for Esophageal Carcinoma. SAGES, (Jan) S271
Khushalani NI*, McKinley BP*, Gibbs JF, Leichman CG, Petrelli NJ. (2003) Regional chemotherapy is indicated after surgical resection of colorectal metastases to the liver: A debate. Journal of Surgical Oncology, (Jan) 65-72
Varma GN*, Winston JS, Hill HC*, Gibbs JF, Proulx GM, McGrath BE, Javle MM. (2003) Gastric Signet Ring Adenocarcinoma Presenting as Diffuse Mass in the Thigh. Journal of Clinical Oncology, (Jan) 3321-3373
Sabel MS*, Mollen K*, Smith J, Nava H, Douglass H, Gibbs JF. (2002) Esophageal resection for carcinoma in patients over 70 years of age. Annals of Surgical Oncology, (Jan) 210-214
Kane JM*, Finley JW*, Driscoll D, Kraybill WG, Gibbs JF. (2002) The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases. Sarcoma, (Jan) 69-73
Chu QD*, Hill HC*, Douglass HO, Driscoll D, Smith JL, Nava HR, Gibbs JF. (2002) Predictive factors associated with long-term survival in patients with neuroendocrine tumor of the pancreas. Annals of Surgical Oncology, (Jan) 855-862
Al-kasspooles MF*, Hill HC*, Nava HR, Smith JL, Douglass HO, Gibbs JF. (2002) High-grade dysplasia within Barrett’s esophagus: Controversies regarding clinical opinions and approaches. Annals of Surgical Oncology, (Jan) 322-327
Kane JM*, Kahlenberg MS*, Kanter PM, Weber TK, Gibbs JF, Rodriguez-Bigas MA, Petrelli NJ. (2002) Intraoperative hepatic lymphatic mapping in patients with colorectal liver metastases. American Surgeon, (Jan) 745-750
Sabel MS*, Gibbs JF, Litwin A, McGrath B, Kraybill WG, Brooks JJ. (2001) Alveolar soft part sarcoma metastatic to small bowel mucosa causing polyposis and intusseption. Sarcoma, (Jan) 133-138
Wu D*, Gibbs J, Corral D, Intengan M, Brooks JJ. (2000) Massive localized lymphedema: Additional locations and association with hypothyroidism. Human Pathology, (Jan) 1162-1168
Proulx GM, Gibbs JF, Lee RJ, Velagapudi S, Huben R. (1999) Sarcomas of the Bladder: A case report with a review of the literature. Radiology and Oncology, (Jan) 63-68
Fuchshuber PR*, McGrath BE, Gibbs JF, Kraybill WG, Proulx GM, Lee, RJ. (1999) Second Malignancy after Radiotherapy for Seminoma. Radiology and Oncology, (Jan) 59-61
Kane III J, Gibbs J, Kraybill W. (1999) The Treatment and Outcome of Patients with Soft Tissue Sarcomas and Synchronous Metastases. Connective Tissue Oncology Society, Washington, D.C., (Jan)
Fuchshuber PR*, Lipman B, Kraybill WG, Gibbs JF. (1998) Ecthyma Gangrenosum Secondary to E. Coli Sepsis. Infections in Medicine, (Jan) 798-801
Schober C, Yin M-b, Gibbs J, Rustum Y. (1995) Heterogeneity in DNA Damage and Repair of Human Ovarian Tumor Cells Treated with Doxorubicin. Cellular Pharmacology, (Jan) 177-181